NCT02388035View on ClinicalTrials.gov

Cefotaxime Resistance in Treatment of Spontaneous Bacterial Peritonitis

NACompletedINTERVENTIONAL
Enrollment

254

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

June 30, 2015

Conditions
Spontaneous Bacterial Peritonitis
Interventions
DRUG

Cefotaxime

Trial Locations (1)

Unknown

Nasser institute, Cairo

All Listed Sponsors
lead

Dr Ahmed Ali Elbaz

OTHER_GOV

NCT02388035 - Cefotaxime Resistance in Treatment of Spontaneous Bacterial Peritonitis | Biotech Hunter | Biotech Hunter